EGFRAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDoseDenseTherapyEstrogen/EstradiolAntiemeticsCytotoxicTyrosine-KinaseInhibitorNeoadjuvantTherapyOligometastasesAyurvedaPrecisionMedicineLymphNodeStatusTriple +/-BreastCancerCheckpointInhibitorPalbociclibCalcificationsCapecitabineTumorGradeAdjuvantTherapyBiopsy5-FluorouracilSelf-examinationAdvocacyGuaranteedRenewableInsuranceRadiotherapyKappaEpsilonAbsoluteRiskCo-survivorLumpAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMetastasisPI3KinaseInhibitorsGeneticCounselingFlowCytometryDimplingmTORInhibitorsIn-situCarcinomaMorpheaBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyLymphoscintigraphyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearDocetaxelWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.StagingKi-67RateRaloxifeneMethotrexateHER-2LapatinibBevacizumabHerceptinBreastTomosynthesisMultimodalityTherapyMastectomyECOGScoreRelapseGermlineMutationACChemotherapyCachexiaDoxorubicinMRIGeneticPredispositionProgestinPalpationAnastrozoleMultifocalTumorsHormoneReplacementTherapyFamilyHistoryPaclitaxelMegestrolAcetateDefinitiveSurgeryBRCAGeneChemopreventionBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LCISBilateralProphylacticMastectomyAdenocarcinomaPhyllodesTumorOvarianSuppressionChemotherapyAromataseInhibitorsBrachytherapyImmunotherapyPhysicalactivity mayreduce therisk of breastcancersLumpectomyFISHGailModelGeneMutationBI-RADSMastodyniaTamoxifenCytostaticApoptosisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCMFChemotherapyER+/-FibroadenomaPARPInhibitorsRADPagetDiseaseCDK4/6InhibitorsHormoneReceptorStatusAngiogenesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.IntraductalPapillomaCAM1 in 8womenCyclophosphamideSERMBOCAAntibodyTherapyPathologicResponseAlopeciaDown-StagingCystEGFRAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDoseDenseTherapyEstrogen/EstradiolAntiemeticsCytotoxicTyrosine-KinaseInhibitorNeoadjuvantTherapyOligometastasesAyurvedaPrecisionMedicineLymphNodeStatusTriple +/-BreastCancerCheckpointInhibitorPalbociclibCalcificationsCapecitabineTumorGradeAdjuvantTherapyBiopsy5-FluorouracilSelf-examinationAdvocacyGuaranteedRenewableInsuranceRadiotherapyKappaEpsilonAbsoluteRiskCo-survivorLumpAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMetastasisPI3KinaseInhibitorsGeneticCounselingFlowCytometryDimplingmTORInhibitorsIn-situCarcinomaMorpheaBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyLymphoscintigraphyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearDocetaxelWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.StagingKi-67RateRaloxifeneMethotrexateHER-2LapatinibBevacizumabHerceptinBreastTomosynthesisMultimodalityTherapyMastectomyECOGScoreRelapseGermlineMutationACChemotherapyCachexiaDoxorubicinMRIGeneticPredispositionProgestinPalpationAnastrozoleMultifocalTumorsHormoneReplacementTherapyFamilyHistoryPaclitaxelMegestrolAcetateDefinitiveSurgeryBRCAGeneChemopreventionBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LCISBilateralProphylacticMastectomyAdenocarcinomaPhyllodesTumorOvarianSuppressionChemotherapyAromataseInhibitorsBrachytherapyImmunotherapyPhysicalactivity mayreduce therisk of breastcancersLumpectomyFISHGailModelGeneMutationBI-RADSMastodyniaTamoxifenCytostaticApoptosisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCMFChemotherapyER+/-FibroadenomaPARPInhibitorsRADPagetDiseaseCDK4/6InhibitorsHormoneReceptorStatusAngiogenesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.IntraductalPapillomaCAM1 in 8womenCyclophosphamideSERMBOCAAntibodyTherapyPathologicResponseAlopeciaDown-StagingCyst

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. EGFR
  2. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  3. Dose Dense Therapy
  4. Estrogen/Estradiol
  5. Antiemetics
  6. Cytotoxic
  7. Tyrosine-Kinase Inhibitor
  8. Neoadjuvant Therapy
  9. Oligometastases
  10. Ayurveda
  11. Precision Medicine
  12. Lymph Node Status
  13. Triple +/- Breast Cancer
  14. Checkpoint Inhibitor
  15. Palbociclib
  16. Calcifications
  17. Capecitabine
  18. Tumor Grade
  19. Adjuvant Therapy
  20. Biopsy
  21. 5-Fluorouracil
  22. Self-examination
  23. Advocacy
  24. Guaranteed Renewable Insurance
  25. Radiotherapy
  26. Kappa Epsilon
  27. Absolute Risk
  28. Co-survivor
  29. Lump
  30. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  31. Metastasis
  32. PI3 Kinase Inhibitors
  33. Genetic Counseling
  34. Flow Cytometry
  35. Dimpling
  36. mTOR Inhibitors
  37. In-situ Carcinoma
  38. Morphea
  39. Breast Cancer
  40. Women ages 40+ should have a clinical breast exam at least yearly
  41. Lymphoscintigraphy
  42. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  43. Docetaxel
  44. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  45. Staging
  46. Ki-67 Rate
  47. Raloxifene
  48. Methotrexate
  49. HER-2
  50. Lapatinib
  51. Bevacizumab
  52. Herceptin
  53. Breast Tomosynthesis
  54. Multimodality Therapy
  55. Mastectomy
  56. ECOG Score
  57. Relapse
  58. Germline Mutation
  59. AC Chemotherapy
  60. Cachexia
  61. Doxorubicin
  62. MRI
  63. Genetic Predisposition
  64. Progestin
  65. Palpation
  66. Anastrozole
  67. Multifocal Tumors
  68. Hormone Replacement Therapy
  69. Family History
  70. Paclitaxel
  71. Megestrol Acetate
  72. Definitive Surgery
  73. BRCA Gene
  74. Chemoprevention
  75. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  76. LCIS
  77. Bilateral Prophylactic Mastectomy
  78. Adenocarcinoma
  79. Phyllodes Tumor
  80. Ovarian Suppression
  81. Chemotherapy
  82. Aromatase Inhibitors
  83. Brachytherapy
  84. Immunotherapy
  85. Physical activity may reduce the risk of breast cancers
  86. Lumpectomy
  87. FISH
  88. Gail Model
  89. Gene Mutation
  90. BI-RADS
  91. Mastodynia
  92. Tamoxifen
  93. Cytostatic
  94. Apoptosis
  95. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  96. CMF Chemotherapy
  97. ER +/-
  98. Fibroadenoma
  99. PARP Inhibitors
  100. RAD
  101. Paget Disease
  102. CDK4/6 Inhibitors
  103. Hormone Receptor Status
  104. Angiogenesis
  105. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  106. Intraductal Papilloma
  107. CAM
  108. 1 in 8 women
  109. Cyclophosphamide
  110. SERM
  111. BOCA
  112. Antibody Therapy
  113. Pathologic Response
  114. Alopecia
  115. Down-Staging
  116. Cyst